Heather Huet

Unexpected hepatotoxicity in a phase I study of TAS266, a novel tetravalent agonistic Nanobody® targeting the DR5 receptor

Kyriakos P. Papadopoulos, Randi Isaacs, Sanela Bilic et al. · Cancer Chemotherapy and Pharmacology · 2015 · 149 citations

Nanomedicine, Drug Target, Drug Targeting +9

Multivalent nanobodies targeting death receptor 5 elicit superior tumor cell killing through efficient caspase induction

Heather Huet, Joseph D. Growney, Jennifer Johnson et al. · mAbs · 2014 · 104 citations · Full text

Nanotherapeutics, Engineering, Immunology +25

RON<i>(MST1R)</i>is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma

Daniel V.T. Catenacci, Gustavo M. Cervantes, Soheil Yala et al. · Cancer Biology & Therapy · 2011 · 103 citations

Engineering, Esophageal Cancer, Gastroenterology +18

Pre-clinical validation of B cell maturation antigen (BCMA) as a target for T cell immunotherapy of multiple myeloma

Dexiu Bu, Reshma Singh, Eugene Choi et al. · Oncotarget · 2018 · 70 citations · Full text

Effector-Mediated Eradication of Precursor B Acute Lymphoblastic Leukemia with a Novel Fc-Engineered Monoclonal Antibody Targeting the BAFF-R

Reshmi Parameswaran, Min Lim, Fei Fei et al. · Molecular Cancer Therapeutics · 2014 · 37 citations · Full text

Effector-mediated Eradication, Immunology, Immune Regulation +19